MetaBet Real-Time Odds API & Live Sports Betting Feeds

This website is using a security service to protect itself from online attacks. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.

Our Products

(1) reduction of hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis; (2) in muscle, by increasing insulin sensitivity, improving peripheral glucose uptake and utilisation; (3) delay of intestinal glucose absorption. Hypoglycaemia has not been seen with metformin doses of up to 85g, although lactic acidosis has occurred in such circumstances. Inducers of OCT1 (such as rifampicin) may increase gastrointestinal absorption and efficacy of metformin. Metformin alone does not cause hypoglycaemia, although caution is advised when it is used in combination with insulin or other oral antidiabetics (e.g. sulfonylureas or meglitinides). Due to the potential for decreased renal function in elderly subjects, the metformin dosage should be adjusted based on renal function.

7 Effects on ability to drive and use machines

More frequent blood glucose monitoring may be required, especially at the beginning of treatment. If necessary, adjust the metformin dosage during therapy with the other drug and upon its discontinuation. Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Our no-code tiles allow you to display game, player, team, and league prop bets. Powered by our Odds API, you can rest assured knowing that your audience is seeing the latest odds across any and all major sportsbooks.

NAME OF THE MEDICINAL PRODUCT

Metformin should be discontinued prior to or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable, see sections 4.2 and 4.5. No accumulation is observed after repeated administration of up to 2000mg of metformin as prolonged release tablets. Metformin and insulin may be used in combination therapy to achieve better blood glucose control. The usual starting dose of Metabet SR is one 500 mg tablet once daily, while insulin dosage is adjusted on the basis of blood glucose measurements. The dose of Metabet SR / Bolamyn SR / Metformin 1000 mg prolonged-release tablets should be equivalent to the daily dose of metformin in tablets (prolonged or immediate release), up to a maximum dose of 2000 mg given with the evening meal. Dosage increases should be made in increments of 500 mg every 10–15 days, up to a maximum of 2000 mg once daily with the evening meal.

What is a Sports Equinox?

In type 1 diabetes, the combination of metformin and insulin has been used in selected patients, but the clinical benefit of this combination has not been formally established. To prevent one case of overt diabetes during the three years in the whole population of the DPP, 6.9 patients had to participate in the intensive lifestyle group and 13.9 in the metformin group. The point of reaching a cumulative incidence of diabetes equal to 50% was delayed by about three years in the metformin group compared to placebo. However, patients should be alerted to the risk of hypoglycaemia when metformin is used in combination with other antidiabetic agents (sulfonylureas, insulin or meglitinides). However, as only limited data are available, breast-feeding is not recommended during metformin treatment. A decision on whether to discontinue breast-feeding should be made, taking into account the benefit of breast-feeding and the potential risk to adverse effects on the child.

• PVC/PVDC/Aluminium blister- Blister packs of 7, 10, 14, 20, 28, 30, 56, 60, 84, 90, 100 and 112 tablets.
• Metformin should only be considered where intensive lifestyle modifications for 3 to 6 months have not resulted in adequate glycaemic control.
• The usual starting dose of Metabet SR is one 500 mg tablet once daily, while insulin dosage is adjusted on the basis of blood glucose measurements.
• The point of reaching a cumulative incidence of diabetes equal to 50% was delayed by about three years in the metformin group compared to placebo.
• The maximum recommended dose is 2 tablets of Metabet SR / Bolamyn SR / Metformin 1000 mg tablet daily.
• Intrasubject variability of Cmax and AUC of metformin prolonged release is comparable to that observed with metformin immediate release tablets.
• The red blood cells most likely represent a secondary compartment of distribution.
• Following a single oral administration in the fed state of one tablet of metformin SR 1000 mg, a mean peak plasma concentration of 1214 ng/ml is achieved with a median time of 5 hours (range of 4 to 10 hours).

3 Preclinical safety data

When starting or using such products in combination with metformin, close monitoring of renal function is necessary. In patients already treated with metformin tablets, the starting dose of Metabet SR / Bolamyn SR / Metformin should be equivalent to the daily dose of metformin immediate release tablets. In patients treated with metformin at a dose above 2000 mg daily, switching to Metformin sustained release tablets is not recommended. When the patient plans to become pregnant and during pregnancy, it is recommended that impaired glycaemic control or diabetes are not treated with metformin. For diabetes it is recommended that insulin should be used to maintain blood glucose levels as close to normal as possible to reduce the risk of malformations of the foetus. Intravascular administration of iodinated contrast agents may lead to contrast induced nephropathy, resulting in metformin accumulation and an increased risk of lactic acidosis.

Prop Tiles

If needed, dose adjustment of metformin may be considered as OCT inhibitors/inducers may alter the efficacy of metformin. Due to the limited therapeutic efficacy data in the reduction of risk or delay of type 2 diabetes in patients 75 years and older, metformin initiation is not recommended in these patients. When renal function is impaired, renal clearance is decreased in proportion to that of creatinine and thus the elimination half-life is prolonged, leading to increased levels of metformin in plasma.

Uncover the sports betting value in your content.

With just one line of code, you can tap into customizable product solutions that fit your unique audience. During treatment initiation, the most common adverse reactions are nausea, vomiting, diarrhoea, abdominal pain and loss of appetite, which resolve spontaneously in most cases. A limited amount of data from the use of metformin in pregnant women does not indicate an increased risk of congenital abnormalities. Animal studies do not indicate harmful effects with respect to pregnancy, embryonic or foetal development, parturition or post-natal development (see section 5.3). Inhibitors of OCT2 (such as cimetidine, dolutegravir, ranolazine, trimethoprim, vandetanib, isavuconazole) may decrease the renal elimination of metformin and thus lead to an increase in metformin plasma concentration. Metformin must be discontinued prior to or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable, see sections 4.2 and 4.4..

Sports Excitement Analytics

When the prolonged release tablet is administered in fasting conditions the AUC is decreased by 30% (both Cmax and Tmax are unaffected). Patients with heart failure are more at risk of hypoxia and renal insufficiency. In patients with stable chronic heart failure, metformin may be used with a regular monitoring of cardiac and renal function.

• Therapy may be restarted no earlier than 48 hours following surgery or resumption of oral nutrition and provided that renal function has been re-evaluated and found to be stable.
• The maximum recommended dose is 4 tablets (2000 mg) once daily with the evening meal.
• Treatment with Metabet SR / Bolamyn SR / Metformin must be based on a risk score incorporating appropriate measures of glycaemic control and including evidence of high cardiovascular risk (see section 5.1).
• Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.
• Available in JSON or XML formats, let us handle the mapping, normalization, and constant updating so you can focus on content creation.
• Intravascular administration of iodinated contrast agents may lead to contrast induced nephropathy, resulting in metformin accumulation and an increased risk of lactic acidosis.
• In case of dehydration (severe diarrhoea or vomiting, fever or reduced fluid intake), metformin should be temporarily discontinued and contact with a health care professional is recommended.

Widgets & Tiles

Available in JSON or XML formats, let us handle the mapping, normalization, and constant updating so you can focus on content creation. Underpinning each of our products is ExpressLinks, our innovative system that can create and embed dynamic and intelligent links that connect users directly to betting slips. Our Semantic Engine extracts meaning from your sports content and automatically inserts text and widgets that deep-link directly to sportsbooks and earn you affiliate revenue.

Customizable product solutions to fit your audience.

– still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3 to 6 months. Display odds for the most popular sports in the US and abroad in seconds with our Odds Table. One line of code allows your audience to compare odds from all the major sportsbooks.

• We take care of all the heavy lifting behind the scenes, so you can just focus on creating engaging betting content.
• When the 1000 mg prolonged release tablet is administered in fed conditions the AUC is increased by 77% (Cmax is increased by 26% and Tmax is slightly prolonged by about 1 hour).
• Some medicinal products can adversely affect renal function which may increase the risk of lactic acidosis, e.g.
• To prevent one case of overt diabetes during the three years in the whole population of the DPP, 6.9 patients had to participate in the intensive lifestyle group and 13.9 in the metformin group.
• – still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3 to 6 months.
• Metabet SR / Bolamyn SR / Metformin 1000 mg prolonged-release tablets are intended for patients who are already treated with metformin tablets (prolonged or immediate release).
• Metformin must be discontinued prior to or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable, see sections 4.2 and 4.4..
• Metformin must be discontinued at the time of surgery under general, spinal or epidural anesthesia.

New DFS and sports betting tools create opportunity for FTN

The maximum recommended dose is 4 tablets (2000 mg) once daily with the evening meal. When the 1000 mg prolonged release tablet is administered in fed conditions the AUC is increased by 77% (Cmax is increased by 26% and Tmax is slightly prolonged by about 1 hour). Caution is therefore advised, especially in patients with renal impairment, when these drugs are co-administered with metformin, as metformin plasma concentration may increase.

Odds Table

Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis). The therapy should be initiated with one tablet Metabet SR 500 mg once daily with the evening meal. Pre-game, In-play, Props, and Futures markets from every major US Sportsbook can be found in our API.

• Inducers of OCT1 (such as rifampicin) may increase gastrointestinal absorption and efficacy of metformin.
• Like all of our products, they’re customizable to meet your brand standards and easy enough for the layman to integrate into your platform.
• MetaBet uncovers the sports betting value in your content with intelligent, engaging integrations that drive sportsbook affiliate revenue.
• The therapy should be initiated with one tablet Metabet SR 500 mg once daily with the evening meal.
• Pre-game, In-play, Props, and Futures markets from every major US Sportsbook can be found in our API.
• We’re a small team of product designers with over 25 years experience delivering engaging consumer solutions at the intersection of sports and technology, for clients in the US and regulated betting markets overseas.

Lactic acidosis, a very rare but serious metabolic complication, most often occurs at acute worsening of renal function or cardiorespiratory illness or sepsis. Metformin accumulation occurs at acute worsening of renal function and increases the risk of lactic acidosis. The available data in subjects with moderate renal insufficiency are scarce and no reliable estimation of the systemic exposure to metformin in this subgroup as compared to subjects with normal renal function could be made. Therefore, the dose adaptation should be made upon clinical efficacy/tole­rability considerations (see section 4.2). Metabet SR/ Bolamyn SR/ Metformin 1000 mg prolonged-release tablets were shown to be bioequivalent to Metabet SR 500 mg at a 1000 mg dose with respect to Cmax and AUC in healthy fed and fasted subjects.

8 Undesirable effects

Combined with our deep-linking capabilities, your audience can quickly and seamlessly find the best odds and be dropped into a populated betslip. Inhibitors of both OCT1 and OCT2 (such as crizotinib, olaparib) may alter efficacy and renal elimination of metformin. We believe that sports betting will become an ever increasing part of sports coverage and conversation. By providing easy-to-implement technology solutions that address regulatory hurdles and other friction points, we will facilitate the seamless convergence of sports wagering and sports content for both consumers and businesses. We’re a small team of product designers with over 25 years experience delivering engaging consumer solutions at the intersection of sports and technology, for clients in the US and regulated betting markets overseas.

Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. Metabet SR / Bolamyn SR / Metformin monotherapy does not cause hypoglycaemia and therefore has no effect on the ability to drive or to use machines. Medicinal products with intrinsic hyperglycaemic activity (e.g. glucocorticoids (systemic and local routes) and sympathomimetics). All patients should continue their diet with a regular distribution of carbohydrate intake during the day. In case of dehydration (severe diarrhoea or vomiting, fever or reduced fluid intake), metformin should be temporarily discontinued and contact with a health care professional is recommended.

SportsContentCo

• Like all of our products, they’re customizable to meet your brand standards and easy enough for the layman to integrate into your platform.
• Pre-game, In-play, Props, and Futures markets from every major US Sportsbook can be found in our API.
• Hypoglycaemia has not been seen with metformin doses of up to 85g, although lactic acidosis has occurred in such circumstances.
• Inhibitors of OCT2 (such as cimetidine, dolutegravir, ranolazine, trimethoprim, vandetanib, isavuconazole) may decrease the renal elimination of metformin and thus lead to an increase in metformin plasma concentration.
• For diabetes it is recommended that insulin should be used to maintain blood glucose levels as close to normal as possible to reduce the risk of malformations of the foetus.
• The therapy should be initiated with one tablet Metabet SR 500 mg once daily with the evening meal.

After 10 to 15 days the dose should be adjusted on the basis of blood glucose measurements. The maximum recommended dose is 2 tablets of Metabet SR / Bolamyn SR / Metformin 1000 mg tablet daily. After 10 to 15 days dose adjustment on the basis of blood glucose measurements is recommended (OGTT and/or FPG and/or HbA1C values to be within the normal range).

If glycaemic control is not achieved on 2000 mg of Metabet SR / Bolamyn SR / Metformin once daily, 1000 mg of Metabet SR / Bolamyn SR / Metformin twice daily should be considered, with both doses being given with food. If glycaemic control is still not achieved, patients may be switched to standard metformin tablets to a maximum dose of 3000 mg daily. After an oral dose of the prolonged release tablet, metformin absorption is significantly delayed compared to the immediate release tablet with a Tmax at 7 hours (Tmax for the immediate release tablet is 2.5 hours). Metabet SR / Bolamyn SR / Metformin 1000 mg prolonged-release tablets are intended for patients who are already treated with metformin tablets (prolonged or immediate release).

Intrasubject variability of Cmax and AUC of metformin prolonged release is comparable to that observed with metformin immediate release tablets. A GFR should be assessed before initiation of treatment with metformin containing products and at least annually thereafter. In patients at an increased risk of further progression of renal impairment and in the elderly, renal function should be assessed more frequently, e.g. every 3–6 months.

Metformin must be discontinued at the time of surgery under general, spinal or epidural anesthesia. Therapy may be restarted no earlier than 48 hours following surgery or resumption of oral nutrition and provided that renal function has been re-evaluated and found to be stable. For patients with acute and unstable heart failure, metformin is contraindicated (see section 4.3). Metformin should only be considered where intensive lifestyle modifications for 3 to 6 months have not resulted in adequate glycaemic control. MetaBet uncovers the sports betting value in your content with intelligent, engaging integrations that drive sportsbook affiliate revenue.

Following a single oral administration in the fed state of one tablet of metformin SR 1000 mg, a mean peak plasma concentration of 1214 ng/ml is achieved with a median time of 5 hours (range of 4 to 10 hours). Fertility of male or female rats was unaffected by metformin when administered at doses as high as 600 mg/kg/day, which is approximately three times the maximum recommended human daily dose based on body surface area comparisons. Factors that may increase the risk of lactic acidosis (see section 4.4) should be reviewed before considering initiation of metformin.

A decision to re-evaluate therapy is also required if the patient subsequently implements improvements to diet and/or exercise, or if changes to the medical condition will allow increased lifestyle interventions to be possible. It is recommended to regularly monitor (every 3–6 months) the glycaemic status (OGTT and/or FPG and/or HbA1c value) as well as the risk factors to evaluate whether treatment needs to be continued, modified or discontinued. Treatment with Metabet SR / Bolamyn SR / Metformin must be based on a risk score incorporating appropriate measures of glycaemic control and including evidence of high cardiovascular risk (see section 5.1). MetaBet is a software company with a suite of easy-to-implement engagement tools that enable contextual integrations of sports betting information. Our products and iGaming monetization services are utilized by leading media companies and industry publishers. Whether you’re a publisher or an operator, focused on sharps or first-time bettors, our customizable, easy-to-implement products will fit your needs.

At steady state, similar to the immediate release formulation, Cmax and AUC are not proportionally increased to the administered dose. The AUC after a single oral administration of 2000mg of metformin prolonged release tablets is similar to that observed after administration of 1000mg of metformin immediate release tablets b.i.d. Some medicinal products can adversely affect renal function which may increase the risk of lactic acidosis, e.g. NSAIDs, including selective cyclo-oxygenase (COX) II inhibitors, ACE inhibitors, angiotensin II receptor antagonists and diuretics, especially loop diuretics.

Metabet SR / Bolamyn SR / Metformin may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin. Mean metformin absorption from the prolonged release formulation is almost not altered by meal composition. Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Allow your audience to search for markets from all major sportsbooks across players, teams, and leagues with a few keystrokes. The blood peak is lower than the plasma peak and appears at approximately the same time. The red blood cells most likely represent a secondary compartment of distribution.

PVC/PVDC/Aluminium blister- Blister packs of 7, 10, 14, 20, 28, 30, 56, 60, 84, 90, 100 and 112 tablets. The advantage of the lifestyle intervention over metformin was greater in older persons. Metformin stimulates intracellular glycogen synthesis by acting on glycogen synthase. Metformin increases the transport capacity of all types of membrane glucose transporters (GLUT). The usual laboratory tests for diabetes monitoring should be performed regularly.

We take care of all the heavy lifting behind the scenes, so you can just focus on creating engaging betting content. For metformin used as second-line therapy, in combination with a sulfonylurea, benefit regarding clinical outcome has not been shown. In clinical studies, the major non glycaemic effect of metformin is either weight stability or modest weight loss.

You can stay focused on creating great content, while metabet creates engaging, revenue-generating integrations. Our automated monetization tools can inject intelligent integrations to extract new value from your sports-focused content. Like all of our products, they’re customizable to meet your brand standards and easy enough for the layman to integrate into your platform.